QT
PHAT icon

Quantbot Technologies’s Phathom Pharmaceuticals PHAT Stock Holding History

Quantbot Technologies’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$464K Buy
+42,755
New +$488K 0.02% 951
2026
Q1 		– Sell
-535
Closed -$8.88K – 2060
2025
Q4 		$8.88K Sell
535
-9,262
-95% -$132K ﹤0.01% 1603
2025
Q3 		$115K Buy
+9,797
New +$101K ﹤0.01% 1418
2023
Q1 		– Sell
-2,927
Closed -$32.8K – 1945
2022
Q4 		$32.8K Sell
2,927
-400
-12% -$4.12K ﹤0.01% 1373
2022
Q3 		$36K Sell
3,327
-2,200
-40% -$21K ﹤0.01% 1296
2022
Q2 		$46K Buy
5,527
+2,927
+113% +$30.1K ﹤0.01% 1319
2022
Q1 		$35K Sell
2,600
-200
-7% -$3.23K ﹤0.01% 1268
2021
Q4 		$55K Buy
2,800
+1,800
+180% +$42.4K ﹤0.01% 1002
2021
Q3 		$32K Buy
+1,000
New +$33.2K ﹤0.01% 1186

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Quantbot Technologies's PHAT Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Phathom Pharmaceuticals (PHAT) in Q2 2026: 42,755 shares worth $464K. The stake represents 0.02% of the portfolio and ranks #951 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in PHAT as recently as Q4 2025.

Quantbot Technologies first reported a position in PHAT in Q3 2021 and has held it in 9 quarters since. 162 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • Quantbot Technologies held 42,755 shares of Phathom Pharmaceuticals worth $464K as of Q2 2026.
  • Phathom Pharmaceuticals was a new Quantbot Technologies position in Q2 2026.
  • Phathom Pharmaceuticals made up 0.02% of Quantbot Technologies's portfolio in Q2 2026, its #951 holding.
  • Quantbot Technologies first reported a position in Phathom Pharmaceuticals in Q3 2021 and has held it in 9 quarters since.
  • 162 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.